Physician profile
Jasjit Sehdev
NPI 1972984334
$10,385.70
in general payments reported to CMS, 2019-2025
19 companies · $2,452 in 2025
The $2,452 reported for 2025 was more than what 86% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,002 · 2020: $498 · 2021: $1,101 · 2022: $739 · 2023: $760 · 2024: $3,833 · 2025: $2,452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,041 · Travel and Lodging: $2,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,041.19 |
| Travel and Lodging | $2,003.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,343.79 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept Rf Probe, General - Pain Management |
| Medtronic, INC. | $2,903.70 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Nevro Corp. | $1,070.28 | 2019-2023 | Senza |
| Abbott Laboratories | $707.33 | 2019-2025 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $479.38 | 2024-2025 | Evoke |
| Globus Medical, INC. | $336.89 | 2025 | Senza |
| Medtronic USA, INC. | $298.00 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $244.04 | 2019-2024 | Xtampza, Belbuca |
| Stryker Corporation | $171.91 | 2025 | Mild Device Kit |
| Biotronik Nro, INC. | $143.48 | 2025 | Prospera |
| Vertos Medical, INC. | $134.16 | 2024 | Mild Device Kit |
| Vertiflex, INC. | $133.74 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $124.99 | 2025 | |
| Si-Bone, INC. | $109.09 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.04 | 2023 | Relistor |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $45.37 | 2019 | |
| Abbvie INC. | $42.64 | 2022-2023 | Botox |
| Grt US Holding, INC. | $14.76 | 2021 | |
| Averitas Pharma INC. | $14.11 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasjit Sehdev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.